Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. TAHOR (atorvastatine)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
  • Date 01 October 2014
  • Documents : 1
  • History
Listen Listen
Add to my selection
    Quote this publication
    Share
    Share on
    Facebook share - facebook.com - new window
    Tweeter share - Partager sur Twitter - twitter.com - new window
    LinkedIn share - linkedin.com - new window
    Print

    TAHOR (atorvastatine)

    Opinions on drugs - Posted on Nov 12 2014

    Reason for request

    Nouvel examen suite au dépôt d'une étude post-inscription

    Documents

    • TAHOR 01102014 AVIS CT13865 Xvox
    All our publications
      Drug therapy Embolism, thrombosis and stenosis Metabolic diseases

    Follow us :

    • Twitter (nouvelle fenêtre)
    • Facebook (nouvelle fenêtre)
    • Youtube (nouvelle fenêtre)
    • LinkedIn (nouvelle fenêtre)
    Haute Autorité de Santé
    Advancing quality in the fields of health and social care services
    • Eunetha.eu
    • Pasq.eu
    • All our publications by topic and type
    • Opinions on medicines
    • Opinions on medical devices
    • INAHTA briefs
    • Français
    • English
    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
    PuLK220E2snAgnEa